Zhejiang Jolly Pharmaceutical Co Ltd Capital Reinvestment Ratio
Zhejiang Jolly Pharmaceutical Co Ltd capital reinvestment ratio. Zhejiang Jolly Pharmaceutical Co Ltd (300181) has a Capital Reinvestment Ratio of 0.05x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥367.02 Million) in capital expenditures (CN¥19.94 Million). Check Zhejiang Jolly Pharmaceutical Co Ltd (300181) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Zhejiang Jolly Pharmaceutical Co Ltd (2007–2025)
Capital reinvestment ratio of Zhejiang Jolly Pharmaceutical Co Ltd from 2007 to 2025. This chart tracks Zhejiang Jolly Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 19 annual periods. Also explore net asset momentum of Zhejiang Jolly Pharmaceutical Co Ltd to track the company's year-over-year net asset growth rate.
Zhejiang Jolly Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2007–2025)
Zhejiang Jolly Pharmaceutical Co Ltd capital reinvestment ratio by year from 2007 to 2025. For the full cash flow conversion analysis, see Zhejiang Jolly Pharmaceutical Co Ltd operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.70x | CN¥411.80 Million | CN¥287.14 Million | ▼ -21.2% |
| 2024 | 0.89x | CN¥297.05 Million | CN¥262.89 Million | ▲ +93.8% |
| 2023 | 0.46x | CN¥288.46 Million | CN¥131.71 Million | ▼ -18.3% |
| 2022 | 0.56x | CN¥318.59 Million | CN¥178.03 Million | ▼ -4.9% |
| 2021 | 0.59x | CN¥251.80 Million | CN¥147.95 Million | ▲ +181.6% |
| 2020 | 0.21x | CN¥279.69 Million | CN¥58.35 Million | ▼ -33.5% |
| 2019 | 0.31x | CN¥128.94 Million | CN¥40.46 Million | ▼ -84.0% |
| 2018 | 1.97x | CN¥78.28 Million | CN¥153.92 Million | ▼ -89.7% |
| 2017 | 19.12x | CN¥6.51 Million | CN¥124.40 Million | ▲ +678.2% |
| 2016 | 2.46x | CN¥58.30 Million | CN¥143.24 Million | ▲ +814.8% |
| 2015 | 0.27x | CN¥97.13 Million | CN¥26.08 Million | ▼ -90.6% |
| 2014 | 2.87x | CN¥13.70 Million | CN¥39.30 Million | ▲ +256.8% |
| 2013 | 0.80x | CN¥29.50 Million | CN¥23.73 Million | ▼ -33.8% |
| 2012 | 1.21x | CN¥30.51 Million | CN¥37.05 Million | ▼ -73.0% |
| 2011 | 4.49x | CN¥13.65 Million | CN¥61.32 Million | ▲ +652.1% |
| 2010 | 0.60x | CN¥64.78 Million | CN¥38.68 Million | ▲ +33.7% |
| 2009 | 0.45x | CN¥43.89 Million | CN¥19.60 Million | ▲ +11.3% |
| 2008 | 0.40x | CN¥31.16 Million | CN¥12.50 Million | ▼ -29.4% |
| 2007 | 0.57x | CN¥16.05 Million | CN¥9.12 Million | — |